Medicare Enrolled
Dr. Padmaja Bojanapally, M.D
Internal Medicine · Dunmore, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bojanapally from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bojanapally?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bojanapally
Dr. Padmaja Bojanapally is an internal medicine specialist in Dunmore, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Bojanapally performed 112,958 Medicare services across 5,393 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bojanapally received a total of $2,271 from 46 pharmaceutical and/or device companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bojanapally is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in PA
$2,271 industry payments
Medicare Practice Summary
Medicare Utilization ↗112,958
Medicare services
Top 0% in PA for internal medicine
5,393
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~6,275 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
29,580 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 19,400 | $43 | $86 |
| Denosumab injection (Prolia/Xgeva) | 17,040 | $18 | $30 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
11,580 | $6 | $27 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,010 | $34 | $125 |
| Iron infusion (Monoferric) | 5,700 | $16 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,072 | $0 | $10 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,680 | $6 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,326 | $8 | $30 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
2,201 | $10 | $35 |
| Injection, granisetron hydrochloride, 100 mcg | 1,450 | $0 | $194 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,241 | $88 | $140 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $60 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
674 | $13 | $40 |
| Iron level test | 674 | $6 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
674 | $9 | $35 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
636 | $81 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
542 | $130 | $190 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
502 | $10 | $40 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
449 | $96 | $250 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
414 | $21 | $100 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 409 | $20 | $75 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
377 | $2 | $10 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
294 | $11 | $50 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
254 | $2 | $215 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
231 | $46 | $150 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
222 | $53 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
198 | $60 | $105 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
178 | $15 | $50 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
173 | $6 | $400 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
166 | $48 | $110 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
152 | $21 | $85 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
150 | $25 | $80 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
142 | $6 | $20 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
134 | $15 | $75 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
124 | $4 | $20 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
124 | $6 | $15 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
116 | $19 | $47 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
105 | $1 | $10 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
56 | $41 | $150 |
| PSA test (prostate cancer screening) | 54 | $18 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $111 | $246 |
| New patient office visit, complex (60-74 min) | 41 | $163 | $295 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | 40 | $20 | $75 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
39 | $14 | $40 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 39 | $339 | $1,500 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
39 | $1 | $10 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
38 | $95 | $285 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
37 | $17 | $40 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
36 | $6 | $17 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
34 | $4 | $16 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
33 | $1 | $9 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
33 | $2 | $14 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
32 | $28 | $100 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
28 | $10 | $50 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
28 | $14 | $55 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
27 | $129 | $237 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
18 | $24 | $150 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
16 | $36 | $105 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $56 | $140 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
14 | $5 | $20 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
12 | $35 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $83 | $196 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
38.8% high complexity
52.3% medium
8.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,271
Total received (2018-2024)
Avg $324/year across 7 years
Top 20% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
123
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,957 (86.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$314 (13.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$497
2023
$474
2022
$233
2021
$49
2020
$15
2019
$342
2018
$661
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SOBI, INC
$108
ABBVIE INC.
$59
Astellas Pharma US Inc
$43
PFIZER INC.
$43
BeiGene USA, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$27
Janssen Biotech, Inc.
$27
AstraZeneca Pharmaceuticals LP
$23
GlaxoSmithKline, LLC.
$23
Amgen Inc.
$19
Mirati Therapeutics, Inc.
$18
Rigel Pharmaceuticals, Inc.
$16
Daiichi Sankyo Inc.
$16
Genentech USA, Inc.
$16
Novartis Pharmaceuticals Corporation
$15
EMD Serono, Inc.
$15
Top 3 companies account for 42.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$172
PFIZER INC.
$157
Seagen Inc.
$138
Genentech USA, Inc.
$138
E.R. Squibb & Sons, L.L.C.
$129
SOBI, INC
$108
Astellas Pharma US Inc
$101
Janssen Biotech, Inc.
$86
AstraZeneca Pharmaceuticals LP
$83
Daiichi Sankyo Inc.
$81
Merck Sharp & Dohme Corporation
$77
GENZYME CORPORATION
$72
BeiGene USA, Inc.
$70
ABBVIE INC.
$59
Lilly USA, LLC
$50
Exelixis Inc.
$43
GlaxoSmithKline, LLC.
$42
Pharmacyclics LLC, An AbbVie Company
$42
Janssen Pharmaceuticals, Inc
$41
EMD Serono, Inc.
$38
Ipsen Biopharmaceuticals, Inc
$37
Takeda Pharmaceuticals U.S.A., Inc.
$36
Seattle Genetics, Inc.
$30
Rigel Pharmaceuticals, Inc.
$30
Celgene Corporation
$28
JAZZ PHARMACEUTICALS INC.
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Gilead Sciences, Inc.
$25
Alexion Pharmaceuticals, Inc.
$25
Helsinn Therapeutics (U.S.), Inc.
$23
Sobi, Inc
$22
Amgen Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$19
TAIHO ONCOLOGY, INC.
$18
Merck Sharp & Dohme LLC
$18
Mirati Therapeutics, Inc.
$18
Myriad Genetic Laboratories, Inc.
$16
Regeneron Healthcare Solutions, Inc.
$16
Puma Biotechnology, Inc.
$15
Dendreon Pharmaceuticals LLC
$14
Pharmacyclics LLC, an AbbVie Company
$13
PharmaEssentia USA Corporation
$13
Incyte Corporation
$13
Taiho Oncology, Inc.
$13
ARRAY BIOPHARMA INC
$13
AbbVie, Inc.
$12
Top 3 companies account for 20.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · Alecensa · Avastin · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CEREZYME · Cabometyx · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FASLODEX · FRUZAQLA · GAZYVA · IBRANCE · IMBRUVICA · INJECTAFER · Imbruvica · Itovebi · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KRAZATI · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUTATHERA · Lonsurf · MEKINIST · MYRISK · NINLARO · Nubeqa · OJJAARA · OPDIVO · PLUVICTO · PROVENGE · Padcev · Perjeta · Pomalyst · REBLOZYL · Rezlidhia · SOMATULINE DEPOT · SUTENT · Stivarga · TASIGNA · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · Venclexta · XALKORI · XARELTO · XTANDI · Xtandi · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
275
Per 100K population
127.4
County median income
$64,691
Nearest hospital
GEISINGER-COMMUNITY MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bojanapally is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement in the top 20% of PA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bojanapally experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bojanapally performed 29,580 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bojanapally receive payments from pharmaceutical companies?
Yes. Dr. Bojanapally received a total of $2,271 from 46 companies across 123 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bojanapally's costs compare to other internal medicine physicians in Dunmore?
Dr. Bojanapally's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bojanapally) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Dunmore
Browse internal medicine physicians in Dunmore ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology